Novo Nordisk CEO says the drugmaker is more active than ever in seeking out deals
Novo Nordisk is looking for deals more than ever before, the CEO of the Danish drugmaker said in an interview
Read More
Eli Lilly and Co
Weight loss and hair loss: The growing hair treatment market from GLP-1s
When Branneisha Cooper first began taking GLP-1 injection Mounjaro in late 2022, she heard online that she could experience temporary
Read More
Amazon launches GLP-1 weight loss program, promising ‘fast, convenient’ access
Amazon GLP-1 treatment Source: Amazon Inc. Amazon is pushing deeper into the booming weight loss market, unveiling Tuesday a new
Read More
UnitedHealth tops quarterly estimates, hikes profit outlook as insurer manages high medical
UnitedHealthcare sign is displayed at its office building in Minnetonka, Minnesota, U.S., Dec. 11, 2025. Tim Evans | Reuters UnitedHealth
Read More
Novo Nordisk’s explosive Wegovy pill launch draws a new wave of patients into GLP-1 weight
After years of trying to lose weight “the right way,” Jane Zuckerman realized that “putting in the work just wasn’t
Read More
Stocks making the biggest moves midday: Eli Lilly, Hasbro, Philip Morris, Intel, Micron &
These are the stocks posting the largest moves in midday trading. This article was originally published by a Cnbc.com. Read
Read More
Stocks making the biggest moves premarket: McCormick, Diageo, Nvidia & more
Check out the companies making the biggest moves premarket: McCormick — Shares rose more than 3% after Unilever confirmed it
Read More
Trump tariff fallout: Some industries grapple with lingering effects one year later
A year after President Donald Trump declared his “liberation day” and imposed sweeping tariffs on imports, kicking off a wave
Read More
FDA approves Eli Lilly’s GLP-1 pill, opening the next phase of the weight loss drug market
The U.S. Food and Drug Administration has approved Eli Lilly’s GLP-1 pill, the company said, a major milestone for the
Read More
Novo Nordisk launches multi-month subscriptions for Wegovy obesity drugs as it tries to
Wegovy semaglutide tablets. Michael Siluk | Universal Images Group | Getty Images Novo Nordisk on Tuesday launched a multi-month subscription
Read More